Cargando…

Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma

The crosstalk among the complement system, immune cells, and mediators of inflammation provides an efficient mechanism to protect the organism against infections and support the repair of damaged tissues. Alterations in this complex machinery play a role in the pathogenesis of different diseases. Co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lasorsa, Francesco, Rutigliano, Monica, Milella, Martina, Ferro, Matteo, Pandolfo, Savio Domenico, Crocetto, Felice, Simone, Simona, Gesualdo, Loreto, Battaglia, Michele, Ditonno, Pasquale, Lucarelli, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671650/ https://www.ncbi.nlm.nih.gov/pubmed/38003705 http://dx.doi.org/10.3390/ijms242216515

Ejemplares similares

Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
por: di Meo, Nicola Antonio, et al.
Publicado: (2022)

MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation
por: Lucarelli, Giuseppe, et al.
Publicado: (2023)

Emerging Biomarkers in Renal Damage
por: Ditonno, Pasquale, et al.
Publicado: (2014)

Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer
por: di Meo, Nicola Antonio, et al.
Publicado: (2022)

Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma
por: Vavallo, Antonio, et al.
Publicado: (2014)

Emerging Urinary Markers of Renal Injury in Obstructive Nephropathy
por: Lucarelli, Giuseppe, et al.
Publicado: (2014)

Diagnostic and Prognostic Role of Preoperative Circulating CA 15-3, CA 125, and Beta-2 Microglobulin in Renal Cell Carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2014)

Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell–Renal Cell Carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2015)

MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome
por: Lucarelli, Giuseppe, et al.
Publicado: (2022)

Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma
por: Gigante, Margherita, et al.
Publicado: (2015)

Long-term renal and cardiovascular outcome of living kidney donors: A single-center retrospective observation study
por: Colucci, Vincenza, et al.
Publicado: (2022)

Pentraxin-3-mediated complement activation in a swine model of renal ischemia/reperfusion injury
por: Divella, Chiara, et al.
Publicado: (2021)

Novel Insights into Autophagy and Prostate Cancer: A Comprehensive Review
por: Loizzo, Davide, et al.
Publicado: (2022)

Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects
por: Ferro, Matteo, et al.
Publicado: (2023)

Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics
por: Ragone, Rosa, et al.
Publicado: (2016)

Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury
por: Castellano, Giuseppe, et al.
Publicado: (2019)

Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2018)

Current Management of Urachal Carcinoma: An Evidence-based Guide for Clinical Practice
por: Loizzo, Davide, et al.
Publicado: (2022)

Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2015)

Pre-Transplant Expression of CCR-2 in Kidney Transplant Recipients Is Associated With the Development of Delayed Graft Function
por: Pontrelli, Paola, et al.
Publicado: (2022)

Quality of Life and Psychological Distress among Patients with Small Renal Masses
por: Vartolomei, Liliana, et al.
Publicado: (2022)

Cytoreductive Nephrectomy and Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives
por: Napolitano, Luigi, et al.
Publicado: (2023)

PMMA-Based Continuous Hemofiltration Modulated Complement Activation and Renal Dysfunction in LPS-Induced Acute Kidney Injury
por: Stasi, Alessandra, et al.
Publicado: (2021)

Multi-omics approach reveals the secrets of metabolism of clear cell—renal cell carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2016)

The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma
por: De Palma, Giuseppe, et al.
Publicado: (2016)

Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma
por: Papale, Massimo, et al.
Publicado: (2017)

Role of Complement in Regulating Inflammation Processes in Renal and Prostate Cancers
por: Netti, Giuseppe Stefano, et al.
Publicado: (2021)

Kinetics of humoral immune response and severity of infection after three doses of SARS-CoV-2 mRNA vaccine in a large cohort of kidney transplant recipients
por: Simone, Simona, et al.
Publicado: (2023)

Robotic partial nephrectomy for large renal Leiomyoma: first case report
por: Franco, Antonio, et al.
Publicado: (2023)

JAK3/STAT5/6 Pathway Alterations Are Associated with Immune Deviation in CD8(+) T Cells in Renal Cell Carcinoma Patients
por: Cavalcanti, Elisabetta, et al.
Publicado: (2010)

Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage
por: Franzin, Rossana, et al.
Publicado: (2020)

Radiotherapy to the Primary Tumor: The First Step of a Tailored Therapy in Metastatic Prostate Cancer
por: Ferro, Matteo, et al.
Publicado: (2022)

Renal involvement in COVID-19: focus on kidney transplant sector
por: Sagnelli, Caterina, et al.
Publicado: (2021)

Corrigendum: Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage
por: Franzin, Rossana, et al.
Publicado: (2021)

Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell Carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2020)

A systematic review of robot-assisted partial nephrectomy outcomes for advanced indications: Large tumors (cT2-T3), solitary kidney, completely endophytic, hilar, recurrent, and multiple renal tumors
por: Pandolfo, Savio Domenico, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cleh4grr3ohcuc73trt919poab